Biochemical and Biophysical Research Communications
Identification of prohibitin as an antigen in Behcet’s disease
Introduction
Behcet’s disease (BD), or Silk Route disease [1], is a recurrent and multi-systemic inflammatory disorder with variable clinical manifestations including mucous membrane ulceration and ocular problems [2], [3], [4]. It involves in almost every organs in human body such as blood vessels, gastrointestinal tract, skin and neurological systems, thus several conditions including nervous system problems, vasculitis, fibromyalgia, eyesight problems, joint pain and swelling are also considered to have relationship with BD [5], [6]. Typically BD arises in both genders young adults and has a worldwide distribution, which is more prevalent in countries of the ancient Silk Route including Japan, Korea, China and so on [7], [8]. The etiology of BD is still unknown, while both genetic background and environmental factors are thought to have contributed to the pathogenesis of BD, besides the autoimmune reaction triggered by an infectious agent has been suggested.
Recently, endothelial cells and anti-endothelial cell antibodies (AECA) are emphasized involved in the pathogenesis of BD, and moreover, some new autoantigens were discovered from various primary vascular endothelial cells [9], [10]. For example, α-enolase and hnRNP-A2/B1 were successively identified as autoantigens of BD in human dermal microvascular endothelial cells (HDMEC) [11], [12]. It was also found new autoantigens in human microvascular endothelial cells (HMVEC) by using the method of cDNA expression library [13]. In this study, we speculate human umbilical vein endothelial cells (HUVEC) might be a substituted target to screen novel autoantigens in BD patients, which had been successfully used to screen the target antigens in patients with anti-neutrophil cytoplasmic antibody-associated vasculitides [14].
Section snippets
Subjects
164 serum samples from patients with Behcet’s disease (BD, 58 cases), systemic lupus erythematosus (SLE, 50 cases) or healthy controls (HC, 56 cases) were enrolled and tested in this study. The institutional review board of the Chinese PLA General Hospital approved the study, and written informed consent was obtained from all the subjects. In addition, diagnosis was based on the criteria proposed by the International Study Group for BD (Criteria for diagnosis of Behcet’s disease, 1990) [15].
Indirect immunofluorescence
By using indirect immunofluorescence on HUVEC, it was displayed a stronger reactivity in cells incubated with sera from BD patients than from healthy volunteers. Despite there has some individual variation, the specific binding immunofluorescence signal was a good indicator to show the autoantibodies in blood circulation from BD patients can recognize the antigen in HUVEC (Fig. 1A and B).
Detection of target autoantigen in HUVEC
The result of ELISA to screen autoantigens in HUVEC with serum samples from 58 BD patients was performed in
Discussion
Prohibitin, which is ubiquitously located in mitochondria, nucleus, and other cellular compartments, is highly conserved and one of the most important members in membrane protein families [18], [19]. Several evidences suggest that PHB participated in some important biological functions, including suppressed tumor, regulated cell proliferation [20], and prevented infection [21]. Furthermore, it is also referred to participate in the development process of many diseases, while its overexpression
Acknowledgments
The authors wish to express their great gratitude to the help of Prof. Dr. Yaping Tian and Dr. Chunyan Zhang from Chinese PLA General Hospital, and Dr. Shutao Sun from Institute of Microbiology Chinese Academy of Sciences for MS analysis.
This work was supported by the Fundamental Research Funds for the Central Universities, Program for New Century Excellent Talents in University and the National Natural Science Foundation of China (No. 31371203).
References (23)
- et al.
Behcet’s disease – a contemporary review
J. Autoimmun.
(2009) Current concepts in the etiology and treatment of Behcet disease
Surv. Ophthalmol.
(2005)- et al.
Serum endocan levels as a marker of disease activity in patients with Behcet disease
J. Am. Acad. Dermatol.
(2014) - et al.
Anti-endothelial cell antibodies and central nervous system involvement in Behcet’s disease
Clinics (Sao Paulo)
(2007) - et al.
Identification of HnRNP-A2/B1 as a target antigen of anti-endothelial cell IgA antibody in Behcet’s disease
J. Invest. Dermatol.
(2012) - et al.
Identification of target antigens of anti-endothelial cell antibodies in patients with anti-neutrophil cytoplasmic antibody-associated vasculitides: a proteomic approach
Clin. Immunol.
(2014) Criteria for diagnosis of Behcet’s disease
Lancet
(1990)- et al.
Regions of evolutionary conservation between the rat and human prohibitin-encoding genes
Gene
(1995) - et al.
Prohibitin: a potential target for new therapeutics
Trends Mol. Med.
(2005) ‘Silk route disease’ (Behcet’s disease)
West. J. Med.
(1988)